Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males

L Eremiasova, JA Hubacek, V Danzig, V Adamkova, L Mrazova, J Pitha, V Lanska, R Cifkova, L Vitek

. 2020 ; 84 (10) : 1779-1785.

Language English Country Japan

Persistent link   https://www.medvik.cz/link/bmc21027542

Grant support
NV15-27109A MZ0 CEP Register

BACKGROUND: The potential antiatherogenic role of bilirubin is generally acknowledged, so the aim of this study was to determine serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in the Czech general population with particular reference to its relationship to the risk of myocardial infarction (MI). Methods and Results: Biochemical markers were analyzed in 2 independent Czech post-MONICA studies (in total, n=3,311), and in 741 male MI patients. TheUGT1A1promoter gene variant (rs81753472) was analyzed in these MI patients and in the first control population cohort (n=717). Medians of serum bilirubin concentrations in the 2 Czech general population cohorts were 9.6 and 9.8 mumol/L (10.7 and 11.3 mumol/L in males, and 8.3 and 8.8 mumol/L in females; P<0.01). The prevalence of GS was 8.9%, twice as high in males compared with females (11.6 vs. 6.1%; P<0.01). TheUGT1A1(TA)7/7promoter repeats significantly influenced serum bilirubin concentrations in the controls, but not in the MI patients. Serum bilirubin concentrations were significantly lower in MI patients (7.7 vs. 10.7 mumol/L; P<0.01), with almost 5-fold lower prevalence of GS. CONCLUSIONS: Serum bilirubin concentrations and the prevalence of GS were determined in the Czech general population. Significantly lower serum bilirubin concentrations were observed in male MI patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21027542
003      
CZ-PrNML
005      
20220404160428.0
007      
ta
008      
211102s2020 ja f 000 0|eng||
009      
AR
024    7_
$a 10.1253/circj.CJ-20-0192 $2 doi
035    __
$a (PubMed)32848115
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Eremiášová, Lenka $7 xx0230282 $u Eremiasova, Lenka. Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University ; 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University.
245    10
$a Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males / $c L Eremiasova, JA Hubacek, V Danzig, V Adamkova, L Mrazova, J Pitha, V Lanska, R Cifkova, L Vitek
520    9_
$a BACKGROUND: The potential antiatherogenic role of bilirubin is generally acknowledged, so the aim of this study was to determine serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in the Czech general population with particular reference to its relationship to the risk of myocardial infarction (MI). <ovid:br/>Methods and Results: Biochemical markers were analyzed in 2 independent Czech post-MONICA studies (in total, n=3,311), and in 741 male MI patients. TheUGT1A1promoter gene variant (rs81753472) was analyzed in these MI patients and in the first control population cohort (n=717). Medians of serum bilirubin concentrations in the 2 Czech general population cohorts were 9.6 and 9.8 mumol/L (10.7 and 11.3 mumol/L in males, and 8.3 and 8.8 mumol/L in females; P<0.01). The prevalence of GS was 8.9%, twice as high in males compared with females (11.6 vs. 6.1%; P<0.01). TheUGT1A1(TA)<ovid:sub>7/7</ovid:sub>promoter repeats significantly influenced serum bilirubin concentrations in the controls, but not in the MI patients. Serum bilirubin concentrations were significantly lower in MI patients (7.7 vs. 10.7 mumol/L; P<0.01), with almost 5-fold lower prevalence of GS. CONCLUSIONS: Serum bilirubin concentrations and the prevalence of GS were determined in the Czech general population. Significantly lower serum bilirubin concentrations were observed in male MI patients.
650    02
$a dospělí $7 D000328
650    12
$a bilirubin $x krev $7 D001663
650    02
$a průřezové studie $7 D003430
650    02
$a ženské pohlaví $7 D005260
650    02
$a genotyp $7 D005838
650    12
$a Gilbertova nemoc $x epidemiologie $x genetika $x krev $7 D005878
650    02
$a glukuronosyltransferasa $x genetika $7 D014453
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    12
$a infarkt myokardu $x epidemiologie $x genetika $x krev $7 D009203
650    02
$a polymorfismus genetický $7 D011110
650    02
$a prevalence $7 D015995
650    02
$a promotorové oblasti (genetika) $7 D011401
650    02
$a prospektivní studie $7 D011446
650    02
$a retrospektivní studie $7 D012189
650    02
$a rizikové faktory $7 D012307
650    02
$a sexuální faktory $7 D012737
651    _2
$a Česká republika $x epidemiologie $7 D018153
700    1_
$a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine.
700    1_
$a Danzig, Vilém, $d 1964- $7 ola2006345267 $u 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University.
700    1_
$a Adámková, Věra, $d 1954- $7 jx20050329003 $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine.
700    1_
$a Mrazova L $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine.
700    1_
$a Piťha, Jan, $d 1964- $7 mzk2003187379 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine.
700    1_
$a Lánská, Věra $7 xx0062305 $u Medical Statistics Unit, Institute for Clinical and Experimental Medicine
700    1_
$a Cífková, Renata, $d 1955- $7 nlk20010094490 $u 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University ; Center for Cardiovascular Prevention, 1st Faculty of Medicine and Thomayer Hospital, Charles University.
700    1_
$a Vítek, Libor, $d 1969- $7 xx0035071 $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University. ; 4th Department of Internal Medicine, 1st Faculty of Medicine Faculty and General Hospital, Charles University.
773    0_
$t Circulation Journal $g Roč. 84, č. 10 (2020), s. 1779-1785 $p Circ J $x def $w MED00007056
773    0_
$p Circ J $g 84(10):1779-1785, 2020 09 25
910    __
$a ABA008 $y p $b sig $z 0
990    __
$a 20211102093047 $b ABA008
991    __
$a 20220404160425 $b ABA008
999    __
$a ok $b bmc $g 1718093 $s 1148066
BAS    __
$a 3
BMC    __
$a 2020 $b 84 $c 10 $d 1779-1785 $x MED00007056 $i def $m Circulation journal
GRA    __
$a NV15-27109A $p MZ0
LZP    __
$a 2021-granty
Back

Find record

Citation metrics

Archiving options